Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2008
-
By Jason Derry — Stem Cell Sciences plc has announced an agreement with Pfizer Ltd., under which Stem Cell Sciences (SCS) will provide services that will support Pfizer's new regenerative medicine unit. The partnership provides Pfizer with access to SCS's research services, cell lines, media, and reagents. SCS provides its stem cell technology to…
-
By Christopher P. Singer — In a Notice published in the Federal Register (73 Fed. Reg. 67750) on Monday, November 17, 2008, the U.S. Patent and Trademark Office announced a new rule that would institute an annual fee for all registered practitioners. The fee will be required for practitioners to maintain active status to…
-
By Donald Zuhn — The U.S. Patent and Trademark Office released its FY 2008 Performance and Accountability Report yesterday and announced that the Office had for the first time "met 100 percent of its Government Performance and Results Act (GPRA) goals." According to the Patent Office, the year-end numbers "demonstrate the agency’s commitment to…
-
By Christopher P. Singer — In a Notice published in the Federal Register (73 Fed. Reg. 47534) on Wednesday, November 12, 2008, the U.S. Patent and Trademark Office announced new fees for the transmittal and search for international applications filed under the Patent Cooperation Treaty (PCT). The fees are designed to recover the estimated…
-
By Kwame Mensah — Last month, King Pharmaceuticals, Inc. announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. (representing a total equity value of approximately $1.6 billion and an enterprise value of approximately $1.4 billion) until 5:00 pm, Eastern time, on…
-
By Kevin E. Noonan — In the Bilski case, the Federal Circuit confirmed that the judges have learned the hard lessons of ten years of Supreme Court reversals. The decision is based solely and completely on what the judges seem to believe is the "test" mandated by Supreme Court precedent, based in large part…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. University of Kansas Center for Research, Inc. v. United States of America2:08-cv-02565; filed November 12, 2008 in the District Court of Kansas…
-
November 17-18, 2008 – Pharmaceutical and Biotech Patent Opinion Writing*** (American Conference Institute) – Boston, MA November 17-18, 2008 – Patent Litigation 2008 (Practising Law Institute) – New York, NY November 19-20, 2008 – Paragraph IV on Trial*** (American Conference Institute) – New York, NY December 1, 2008 – 19th Annual Conference on U.S. Patent…
-
Practising Law Institute (PLI) will be holding a live seminar entitled "Parallel Patent Reexamination and Litigation 2008: The Latest Developments and Their Impact" on December 3, 2008 in San Francisco. The conference will offer presentations on the following topics: • Understanding Patent Reexamination Procedure and the Impact of the Process • Overview of the ex…
-
C5 (UK) will be holding its Structuring and Negotiating Pharma & Biotech Collaborative Agreements conference on January 26-27, 2009 in London, England. The conference will allow attendees to: • Factor takeaways from recent deals and trends into collaborations;• Determine when to introduce M&A considerations into collaboration strategy;• Ensure that collaboration agreements meet competition law guidelines;•…
Patent Docs 